Equites Radar

OSCR · Oscar Health, Inc.

Healthcare PlansUnited StatesAnalyst view: Hold

$28.19

+10.80% last session

End-of-day data · updated 2026-07-28

Bullish4 bullish · 1 bearish technical signals
Consensus: Hold (2.82 from 10 analysts)
To mean target: -14.2%

Market cap

$9B

Enterprise value

$2B

Trailing P/E

Forward P/E

18.7

Dividend yield

Beta

2.34

Avg volume

7M

Employees

2K

2D change

5D change

-2.01%

10D change

-2.61%

30D change

-4.87%

60D change

27.49%

MTD change

-11.16%

YTD change

97.22%

Analyst Outlook

Consensus ratingHold
Recommendation mean (1–5)2.82
Covering analysts10
Mean price target$24.20
Low price target$13.00
Upside to mean target-14.2%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)59.2
50-day MA$27.55
200-day MA$18.76
Price vs 50-day MA+14.0%
Price vs 200-day MA+67.4%
MACD histogram-0.31
Volume vs 3-month avg0.9×
52w low $10.8552w high $32.18

Analyst sentiment over time — OSCR

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-06-10

Latest call per bank · past 12 months

Barclays

Overweight

$35.00

+24.2% vs price
▲ raised from $30.00Upgrade · 2026-06-10

UBS

Neutral

$20.00

-29.1% vs price
▲ raised from $15.00Maintains · 2026-05-07

Jefferies

Hold

$16.00

-43.2% vs price
▲ raised from $10.00Upgrade · 2026-04-20

Wells Fargo

Underweight

$11.00

-61.0% vs price
▼ cut from $14.00Maintains · 2025-11-13

Goldman Sachs

Neutral

$17.00

-39.7% vs price
▲ raised from $0.00Initiates · 2025-10-14

Recent rating actions

DateFirmActionRatingPrice target
2026-06-10BarclaysUpgradeEqual-WeightOverweight$30.00 $35.00
2026-05-26BarclaysMaintainsEqual-Weight$21.00 $30.00
2026-05-07UBSMaintainsNeutral$15.00 $20.00
2026-05-07BarclaysMaintainsEqual-Weight$18.00 $21.00
2026-05-07BairdMaintainsNeutral$15.00 $19.00
2026-05-06Wolfe ResearchInitiatesPeer Perform$0.00
2026-04-20JefferiesUpgradeUnderperformHold$10.00 $16.00
2026-01-09UBSUpgradeSellNeutral$12.00 $17.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 59 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 14.0% above the 50-day MA ($27.55).
  • Price vs 200-day MA: Trading 67.4% above the 200-day MA ($18.76).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.31) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($32.18).

OSCR Price Chart

Loading chart for OSCR

Fundamentals

Revenue (TTM)$13B
EBITDA$0M
Free cash flow$2.0B
Operating cash flow$3.0B
Book value / share$5.57
Net debt / EBITDA-158.8
WACC20.0%
Revenue growth53.00%
Earnings growth126.00%

About Oscar Health, Inc.

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

More in Healthcare Plans

Screen OSCR against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.